NBD AI Bulletin -- Tonghua Dongbao Pharmaceutical Co., Ltd (SH 600867, close price: 10.88 yuan) announced on July 29 that the Company's board of directors on the day approved the proposal to buy back shares worth no more than 360 million yuan. The repurchasing price shall not exceed 15 yuan per share (included) .
The 2020 annual report shows that the main business of Tonghua Dongbao Pharmaceutical is the pharmaceutical industry, real estate industry, building materials industry, accounting for 96.1%, 2.38%, 0.24% of revenue, respectively.
Tonghua Dongbao Pharmaceutical's chairman and general manager is Leng Chunsheng, male, 47 years old, PhD, senior engineer.
(By Gao Han)
Disclaimer: The content and data of this article are for reference only and do not constitute investment advice. Please verify before use. Any action you take upon the information on this website is at your own risk.